|
|
||||||||


*
Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115;
Renal Division and Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, MA 02115;
Department of Pediatric Research, Kantonsspital, Basel, Switzerland;
§
Department of Medicine, University of Michigan, Ann Arbor, MI 48109; and
¶
Renal Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115
Pretransplant exposure to allogeneic lymphocytes can result in donor-specific unresponsiveness and prolonged allograft survival. Intracellular signaling events have been described in anergic T cell clones, but the biochemical events underlying in vivo induced unresponsiveness have not been studied in detail. We employed a TCR transgenic mouse, bearing the 2C TCR, providing adequate numbers of homogenous peripheral T cells to study biochemical aspects of T cell unresponsiveness in vivo. 2C mice exposed to semiallogeneic lymphocytes (H-2b x H-2d) experienced prolonged H-2d cardiac allograft survival, and cells from these mice did not proliferate or make IL-2 in response to alloantigen (H-2d). Importantly, there were marked differences in TCR-associated tyrosine phosphorylation activation patterns. The targets for the unresponsive state appear to be diminished Lck activation and absent ZAP-70 and LAT (linker for activation of T cells) phosphorylation. Our study demonstrates that Ag-induced tolerance in vivo is accompanied by altered early TCR-mediated signaling events.
This article has been cited by other articles:
![]() |
L. Chiodetti, S. Choi, D. L. Barber, and R. H. Schwartz Adaptive Tolerance and Clonal Anergy Are Distinct Biochemical States J. Immunol., February 15, 2006; 176(4): 2279 - 2291. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Long, A. M. Slaiby, A. T. Hagymasi, M. A. Mihalyo, A. C. Lichtler, S. L. Reiner, and A. J. Adler T-bet Down-Modulation in Tolerized Th1 Effector CD4 Cells Confers a TCR-Distal Signaling Defect That Selectively Impairs IFN-{gamma} Expression J. Immunol., January 15, 2006; 176(2): 1036 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Richards, S. L. Dalheimer, M. I. Hertz, and D. L. Mueller Trachea Allograft Class I Molecules Directly Activate and Retain CD8+ T Cells That Cause Obliterative Airways Disease J. Immunol., December 15, 2003; 171(12): 6919 - 6928. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Cho, Z. Chang, J. Elkahwaji, T. L. Scheunemann, E. R. Manthei, M. Colburn, S. J. Knechtle, and M. M. Hamawy Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells Int. Immunol., November 1, 2003; 15(11): 1369 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Munder, E. Bettelli, L. Monney, J. M. Slavik, L. B. Nicholson, and V. K. Kuchroo Reduced Self-Reactivity of an Autoreactive T Cell After Activation with Cross-reactive Non-Self-Ligand J. Exp. Med., November 4, 2002; 196(9): 1151 - 1162. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |